Loading clinical trials...
Loading clinical trials...
The purpose of this registry is to evaluate the outcome of pregnancy in women exposed to VIBATIV at any time during pregnancy. There are no mandated physician visits for the registry.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cumberland Pharmaceuticals
NCT07197892 · Early Pregnancy
NCT07437248 · Pregnancy, Dietary Analysis, and more
NCT06968026 · Recurrent Pregnancy Loss, Anxiety Disorders
NCT06965530 · Pregnancy Related, Prematurity, and more
NCT07015203 · Preeclampsia (PE), Fetal Growth Restriction, and more
Cumberland Pharmaceuticals Inc.
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions